Abstract
Summary
The increasing burden of obesity and growing awareness towards the fat reduction procedures among obese individuals is expected to create a huge growth opportunity for injection lipolysis market around the globe. Lipotherapy or injection lipolysis is a minimally invasive procedure used for the breakdown of fat cells around the injection sites.
Injection lipolysis is also applied in cosmetic surgeries to the patients to reduce the number of fat cells. Injection lipolysis is a non-surgical alternative in which drug mixtures such as deoxycholic acid, in combination with vitamin E,l-carnitine, collagenase, isoproterenol, and hyaluronidase are injected to destroy fat cells.
According to WHO world health statistics report in every six adult one is obese globally and the ratio is also gradually increasing which is expected to create huge growth opportunity for injection lipolysis market. So many surgical procedures are being followed by the obese population, however, the increasing demand for non-invasive procedures also anticipated to accelerate the injection lipolysis market growth.
In April 2015, U.S. FDA approved the deoxycholate acid injection Kybella of Kythera Biopharmaceuticals, Inc. which made the injection lipolysis procedure one of the mainstream minimally invasive technique for body fat loss. The injection lipolysis technique for fat loss is well adopted in European and American countries from the last couple of years while the adoption is a little low in Asia pacific regions.
Growing prevalence of diabetes, obesity and demand for cosmetic surgeries for fat reduction is expected to accelerate the injection lipolysis market growth over forecast years. However, safety concerns due to some side effects of injection lipolysis procedure and the presence of other fat breakdown techniques are also expected to hamper the injection lipolysis to some extent.
The global market for Injection Lipolysis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Injection Lipolysis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Injection Lipolysis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Injection Lipolysis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Injection Lipolysis include Cynosure, Inc., Alma Lasers, Allergan Plc, MerzPharmaGmbh, Candela Medical Ltd., Solta Medical Bausch Health Companies, Inc., Lutronic Corporation, InMode Ltd. and Fotona, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Injection Lipolysis, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Injection Lipolysis by region & country, by Type, and by Application.
The Injection Lipolysis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injection Lipolysis.
Market Segmentation
By Company
Cynosure, Inc.
Alma Lasers
Allergan Plc
MerzPharmaGmbh
Candela Medical Ltd.
Solta Medical Bausch Health Companies, Inc.
Lutronic Corporation
InMode Ltd.
Fotona
Sofwave Medical Ltd.
Sciton Inc.
Segment by Type:
Deoxycholic Acid
Phosphatidylcholine
Others
Segment by Application
Hospitals
Dermatology and Cosmetic Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Injection Lipolysis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Injection Lipolysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Injection Lipolysis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Injection lipolysis is also applied in cosmetic surgeries to the patients to reduce the number of fat cells. Injection lipolysis is a non-surgical alternative in which drug mixtures such as deoxycholic acid, in combination with vitamin E,l-carnitine, collagenase, isoproterenol, and hyaluronidase are injected to destroy fat cells.
According to WHO world health statistics report in every six adult one is obese globally and the ratio is also gradually increasing which is expected to create huge growth opportunity for injection lipolysis market. So many surgical procedures are being followed by the obese population, however, the increasing demand for non-invasive procedures also anticipated to accelerate the injection lipolysis market growth.
In April 2015, U.S. FDA approved the deoxycholate acid injection Kybella of Kythera Biopharmaceuticals, Inc. which made the injection lipolysis procedure one of the mainstream minimally invasive technique for body fat loss. The injection lipolysis technique for fat loss is well adopted in European and American countries from the last couple of years while the adoption is a little low in Asia pacific regions.
Growing prevalence of diabetes, obesity and demand for cosmetic surgeries for fat reduction is expected to accelerate the injection lipolysis market growth over forecast years. However, safety concerns due to some side effects of injection lipolysis procedure and the presence of other fat breakdown techniques are also expected to hamper the injection lipolysis to some extent.
The global market for Injection Lipolysis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Injection Lipolysis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Injection Lipolysis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Injection Lipolysis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Injection Lipolysis include Cynosure, Inc., Alma Lasers, Allergan Plc, MerzPharmaGmbh, Candela Medical Ltd., Solta Medical Bausch Health Companies, Inc., Lutronic Corporation, InMode Ltd. and Fotona, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Injection Lipolysis, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Injection Lipolysis by region & country, by Type, and by Application.
The Injection Lipolysis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injection Lipolysis.
Market Segmentation
By Company
Cynosure, Inc.
Alma Lasers
Allergan Plc
MerzPharmaGmbh
Candela Medical Ltd.
Solta Medical Bausch Health Companies, Inc.
Lutronic Corporation
InMode Ltd.
Fotona
Sofwave Medical Ltd.
Sciton Inc.
Segment by Type:
Deoxycholic Acid
Phosphatidylcholine
Others
Segment by Application
Hospitals
Dermatology and Cosmetic Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Injection Lipolysis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Injection Lipolysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Injection Lipolysis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Injection Lipolysis Product Introduction
1.2 Global Injection Lipolysis Market Size Forecast
1.2.1 Global Injection Lipolysis Sales Value (2019-2030)
1.2.2 Global Injection Lipolysis Sales Volume (2019-2030)
1.2.3 Global Injection Lipolysis Sales Price (2019-2030)
1.3 Injection Lipolysis Market Trends & Drivers
1.3.1 Injection Lipolysis Industry Trends
1.3.2 Injection Lipolysis Market Drivers & Opportunity
1.3.3 Injection Lipolysis Market Challenges
1.3.4 Injection Lipolysis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Injection Lipolysis Players Revenue Ranking (2023)
2.2 Global Injection Lipolysis Revenue by Company (2019-2024)
2.3 Global Injection Lipolysis Players Sales Volume Ranking (2023)
2.4 Global Injection Lipolysis Sales Volume by Company Players (2019-2024)
2.5 Global Injection Lipolysis Average Price by Company (2019-2024)
2.6 Key Manufacturers Injection Lipolysis Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Injection Lipolysis Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Injection Lipolysis
2.9 Injection Lipolysis Market Competitive Analysis
2.9.1 Injection Lipolysis Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Injection Lipolysis Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Lipolysis as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Deoxycholic Acid
3.1.2 Phosphatidylcholine
3.1.3 Others
3.2 Global Injection Lipolysis Sales Value by Type
3.2.1 Global Injection Lipolysis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Injection Lipolysis Sales Value, by Type (2019-2030)
3.2.3 Global Injection Lipolysis Sales Value, by Type (%) (2019-2030)
3.3 Global Injection Lipolysis Sales Volume by Type
3.3.1 Global Injection Lipolysis Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Injection Lipolysis Sales Volume, by Type (2019-2030)
3.3.3 Global Injection Lipolysis Sales Volume, by Type (%) (2019-2030)
3.4 Global Injection Lipolysis Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Dermatology and Cosmetic Clinics
4.1.3 Ambulatory Surgical Centers
4.2 Global Injection Lipolysis Sales Value by Application
4.2.1 Global Injection Lipolysis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Injection Lipolysis Sales Value, by Application (2019-2030)
4.2.3 Global Injection Lipolysis Sales Value, by Application (%) (2019-2030)
4.3 Global Injection Lipolysis Sales Volume by Application
4.3.1 Global Injection Lipolysis Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Injection Lipolysis Sales Volume, by Application (2019-2030)
4.3.3 Global Injection Lipolysis Sales Volume, by Application (%) (2019-2030)
4.4 Global Injection Lipolysis Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Injection Lipolysis Sales Value by Region
5.1.1 Global Injection Lipolysis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Injection Lipolysis Sales Value by Region (2019-2024)
5.1.3 Global Injection Lipolysis Sales Value by Region (2025-2030)
5.1.4 Global Injection Lipolysis Sales Value by Region (%), (2019-2030)
5.2 Global Injection Lipolysis Sales Volume by Region
5.2.1 Global Injection Lipolysis Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Injection Lipolysis Sales Volume by Region (2019-2024)
5.2.3 Global Injection Lipolysis Sales Volume by Region (2025-2030)
5.2.4 Global Injection Lipolysis Sales Volume by Region (%), (2019-2030)
5.3 Global Injection Lipolysis Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Injection Lipolysis Sales Value, 2019-2030
5.4.2 North America Injection Lipolysis Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Injection Lipolysis Sales Value, 2019-2030
5.5.2 Europe Injection Lipolysis Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Injection Lipolysis Sales Value, 2019-2030
5.6.2 Asia Pacific Injection Lipolysis Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Injection Lipolysis Sales Value, 2019-2030
5.7.2 South America Injection Lipolysis Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Injection Lipolysis Sales Value, 2019-2030
5.8.2 Middle East & Africa Injection Lipolysis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Injection Lipolysis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Injection Lipolysis Sales Value
6.2.1 Key Countries/Regions Injection Lipolysis Sales Value, 2019-2030
6.2.2 Key Countries/Regions Injection Lipolysis Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Injection Lipolysis Sales Value, 2019-2030
6.3.2 United States Injection Lipolysis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Injection Lipolysis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Injection Lipolysis Sales Value, 2019-2030
6.4.2 Europe Injection Lipolysis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Injection Lipolysis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Injection Lipolysis Sales Value, 2019-2030
6.5.2 China Injection Lipolysis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Injection Lipolysis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Injection Lipolysis Sales Value, 2019-2030
6.6.2 Japan Injection Lipolysis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Injection Lipolysis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Injection Lipolysis Sales Value, 2019-2030
6.7.2 South Korea Injection Lipolysis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Injection Lipolysis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Injection Lipolysis Sales Value, 2019-2030
6.8.2 Southeast Asia Injection Lipolysis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Injection Lipolysis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Injection Lipolysis Sales Value, 2019-2030
6.9.2 India Injection Lipolysis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Injection Lipolysis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cynosure, Inc.
7.1.1 Cynosure, Inc. Company Information
7.1.2 Cynosure, Inc. Introduction and Business Overview
7.1.3 Cynosure, Inc. Injection Lipolysis Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Cynosure, Inc. Injection Lipolysis Product Offerings
7.1.5 Cynosure, Inc. Recent Development
7.2 Alma Lasers
7.2.1 Alma Lasers Company Information
7.2.2 Alma Lasers Introduction and Business Overview
7.2.3 Alma Lasers Injection Lipolysis Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Alma Lasers Injection Lipolysis Product Offerings
7.2.5 Alma Lasers Recent Development
7.3 Allergan Plc
7.3.1 Allergan Plc Company Information
7.3.2 Allergan Plc Introduction and Business Overview
7.3.3 Allergan Plc Injection Lipolysis Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Allergan Plc Injection Lipolysis Product Offerings
7.3.5 Allergan Plc Recent Development
7.4 MerzPharmaGmbh
7.4.1 MerzPharmaGmbh Company Information
7.4.2 MerzPharmaGmbh Introduction and Business Overview
7.4.3 MerzPharmaGmbh Injection Lipolysis Sales, Revenue and Gross Margin (2019-2024)
7.4.4 MerzPharmaGmbh Injection Lipolysis Product Offerings
7.4.5 MerzPharmaGmbh Recent Development
7.5 Candela Medical Ltd.
7.5.1 Candela Medical Ltd. Company Information
7.5.2 Candela Medical Ltd. Introduction and Business Overview
7.5.3 Candela Medical Ltd. Injection Lipolysis Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Candela Medical Ltd. Injection Lipolysis Product Offerings
7.5.5 Candela Medical Ltd. Recent Development
7.6 Solta Medical Bausch Health Companies, Inc.
7.6.1 Solta Medical Bausch Health Companies, Inc. Company Information
7.6.2 Solta Medical Bausch Health Companies, Inc. Introduction and Business Overview
7.6.3 Solta Medical Bausch Health Companies, Inc. Injection Lipolysis Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Solta Medical Bausch Health Companies, Inc. Injection Lipolysis Product Offerings
7.6.5 Solta Medical Bausch Health Companies, Inc. Recent Development
7.7 Lutronic Corporation
7.7.1 Lutronic Corporation Company Information
7.7.2 Lutronic Corporation Introduction and Business Overview
7.7.3 Lutronic Corporation Injection Lipolysis Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Lutronic Corporation Injection Lipolysis Product Offerings
7.7.5 Lutronic Corporation Recent Development
7.8 InMode Ltd.
7.8.1 InMode Ltd. Company Information
7.8.2 InMode Ltd. Introduction and Business Overview
7.8.3 InMode Ltd. Injection Lipolysis Sales, Revenue and Gross Margin (2019-2024)
7.8.4 InMode Ltd. Injection Lipolysis Product Offerings
7.8.5 InMode Ltd. Recent Development
7.9 Fotona
7.9.1 Fotona Company Information
7.9.2 Fotona Introduction and Business Overview
7.9.3 Fotona Injection Lipolysis Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Fotona Injection Lipolysis Product Offerings
7.9.5 Fotona Recent Development
7.10 Sofwave Medical Ltd.
7.10.1 Sofwave Medical Ltd. Company Information
7.10.2 Sofwave Medical Ltd. Introduction and Business Overview
7.10.3 Sofwave Medical Ltd. Injection Lipolysis Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Sofwave Medical Ltd. Injection Lipolysis Product Offerings
7.10.5 Sofwave Medical Ltd. Recent Development
7.11 Sciton Inc.
7.11.1 Sciton Inc. Company Information
7.11.2 Sciton Inc. Introduction and Business Overview
7.11.3 Sciton Inc. Injection Lipolysis Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Sciton Inc. Injection Lipolysis Product Offerings
7.11.5 Sciton Inc. Recent Development
8 Industry Chain Analysis
8.1 Injection Lipolysis Industrial Chain
8.2 Injection Lipolysis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Injection Lipolysis Sales Model
8.5.2 Sales Channel
8.5.3 Injection Lipolysis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer